World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 10 April 2023
Main ID:  NCT02908308
Date of registration: 16/09/2016
Prospective Registration: Yes
Primary sponsor: Helsingborgs Hospital
Public title: Targeted Hypothermia Versus Targeted Normothermia After Out-of-hospital Cardiac Arrest TTM-2
Scientific title: Targeted Hypothermia Versus Targeted Normothermia After Out-of-hospital Cardiac Arrest (TTM2) - A Randomised Clinical Trial
Date of first enrolment: November 18, 2017
Target sample size: 1900
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02908308
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Australia Austria Belgium Czech Republic Czechia Denmark France Germany
Italy Luxembourg Netherlands New Zealand Norway Sweden Switzerland United Kingdom
United States
Contacts
Name:     Paul Young, MD
Address: 
Telephone:
Email:
Affiliation:  Wellington Regional Hospital
Name:     Matt P Wise, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  University Hospital of Wales, Cardiff, UK
Name:     Hans Kirkegaard, MD,PhD
Address: 
Telephone:
Email:
Affiliation:  Aarhus University Hospital
Name:     Christian Storm, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Charité-University Medicine (Berlin, Germany)
Name:     Michael Ioannidis, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Innsbruck University Hospital
Name:     Hans Friberg, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Lund University Hospital, Lund, Sweden
Name:     Tobias Cronberg, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Lund University Hospital, Lund, Sweden
Name:     Per Nordberg, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Södersjukhuset, Stockholm
Name:     Clifton W Callaway, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  University of Pittsburgh, Pittsburgh, USA
Name:     Jan Belholavek, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Prague University Hospital
Name:     Manoj Saxena, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  The George Institute for Global Health (Sydney, Australia)
Name:     Mauro Oddo, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Université de Lausanne, Lausanne, Switzerland
Name:     Alain Cariou, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Université Paris Descartes, France
Name:     Alistair Nichol, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Department of Anaesthesia and Intensive Care Medicine, St Vincent's University Hospital
Name:     Niklas Nielsen, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Helsingborgs lasarett, Region Skåne, Sweden
Name:     Paolo Pelosi, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  San Martino University Hospital, Genoa
Name:     Josef Dankiewicz, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Skåne University Hospital Lund
Name:     Fabio Taccone, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Hopital Erasme, Brussles, Belgium
Name:     David Erlinge, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Lund University Hospital, Lund, Sweden
Name:     Jan Hovdenes, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Oslo University Hospital, Oslo, Norway
Name:     Christian Rylander, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Sahlgrenska University Hospital, Gothenburg, Sweden
Key inclusion & exclusion criteria

Inclusion Criteria:

- Out-of-hospital cardiac arrest

- Presumed cardiac cause of cardiac arrest

- Unconscious with a FOUR-score
- Stable return of spontaneous circulation (20 min)

- Eligible for intensive care treatment without restrictions

- Inclusion within 180 minutes of ROSC

Exclusion Criteria:

- Unwitnessed cardiac arrest with an initial rhythm of asystole

- Temperature on admission <30°C.

- On ECMO prior to ROSC

- Obvious or suspected pregnancy

- Intracranial bleeding

- On ECMO prior to ROSC

- Severe chronic obstructive pulmonary disorder (COPD) with long-term home oxygen
therapy



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Out-of-hospital Cardiac Arrest
Intervention(s)
Procedure: Standard care with early treatment of fever
Procedure: Targeted temperature management to 33°C
Primary Outcome(s)
Mortality [Time Frame: 180 days]
Secondary Outcome(s)
Days alive outside hospital [Time Frame: 180 days.]
Poor functional outcome [Time Frame: 180 days]
Survival until end of the trial [Time Frame: 180 days after randmomization of the last patient]
Quality of Life [Time Frame: 180 days]
Secondary ID(s)
TTM-2
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Clinical Trials Sweden, Forum South
Lund University
Region Skåne - Skånevård SUND
Copenhagen Trial Unit, Center for Clinical Intervention Research
Integrated Biobank of Luxembourg
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history